SCHEMBL5656259

SCHEMBL5656259

Cc1nc2c(O)ccc(C(=O)N(C)C)c2n1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4A O75164 5/20 0.45
L3MBTL1 Q9Y468 2/20 0.36
KDM4E B2RXH2 6/20 0.34
GLA P06280 1/20 0.34
ALDH1A1 P00352 2/20 0.34
GAA P10253 1/20 0.34
PABPC1 P11940 1/20 0.34
HPGD P15428 1/20 0.34
CASP1 P29466 1/20 0.34
HTT P42858 1/20 0.34
HSD17B10 Q99714 1/20 0.34
LMNA P02545 1/20 0.33
COMT P21964 1/20 0.33
KDM6B O15054 1/20 0.32
KDM6A O15550 1/20 0.32
TET3 O43151 1/20 0.32
KDM4B O94953 1/20 0.32
KDM5C P41229 1/20 0.32
KDM4D Q6B0I6 1/20 0.32
TET2 Q6N021 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2268387 0.77 OPRK1 (0.37) KDM4EALDH1A1GAAHPGDHTT
Bromide SCHEMBL5315408 0.76 OPRK1 (0.36) KDM4EALDH1A1GAAHPGDHTT
SCHEMBL5656761 0.70 PDK1 (0.32) L3MBTL1KDM4EALDH1A1GAAHSD17B10
SCHEMBL5564735 0.68 KMT2A (0.36) ALDH1A1LMNAMEN1KMT2ASMN1; SMN2
SCHEMBL3555267 0.68 ALDH1A1 (0.34) KDM4EALDH1A1GAAPABPC1HPGD
SCHEMBL4574787 0.65 MEN1 (0.33) ALDH1A1GAALMNAMEN1KMT2A
SCHEMBL38665048 0.62 GABRP (0.40) KDM4AKDM4EGLAALDH1A1HPGD
SCHEMBL6585743 0.62 ALOX15 (0.52) L3MBTL1KDM4EALDH1A1HPGDHTT
SCHEMBL12261016 0.62 CSNK2A1 (0.62) L3MBTL1KDM4EALDH1A1GAAHPGD
SCHEMBL28138849 0.61 CTSK (0.36) KDM4EGLAALDH1A1GAAPABPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7307084-B2 Cyclic benzimidazoles ALTANA PHARMA AG (DE) 2007-12-11 US disclosed
US-20060194968-A1 Cyclic benizimidazoles ALTANA PHARMA AG (DE) 2006-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194968-A1 Cyclic benizimidazoles VIP, SI, GIPR KDM4A 2109/4885L3MBTL1 2153/4885KDM4E 1927/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.